865
Views
5
CrossRef citations to date
0
Altmetric
Clinial Research

Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose

, , , , , , , , & show all
Pages 197-204 | Received 23 Mar 2021, Accepted 22 Jun 2021, Published online: 19 Jul 2021

References

  • Colon-Berezin C, Nolan ML, Blachman-Forshay J, et al. Overdose deaths involving fentanyl and fentanyl analogs – New York City, 2000–2017. Morb Mortal Wkly Rep. 2019;68(2):37–40.
  • Han Y, Yan W, Zheng Y, et al. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Trans Psychiatry. 2019;9(1):282.
  • Baselt RC. Disposition of toxic drugs and chemicals in man. 12th ed. Seal Beach (CA): Biomedical Publications; 2020.
  • Olson KN, Luckenbill K, Thompson J, et al. Postmortem redistribution of fentanyl in blood. Am J Clin Pathol. 2010;133(3):447–453.
  • Griswold MK, Chai PR, Krotulski AJ, et al. Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose. Clin Toxicol. 2018;56(1):37–42.
  • Griswold MK, Chai PR, Krotulski AJ, et al. A novel oral fluid assay (LC-QTOF-MS) for the detection of fentanyl and clandestine opioids in oral fluid after reported heroin overdose. J Med Toxicol. 2017;13(4):287–292.
  • Krotulski AJ, Varnum SJ, Logan BK. Sample mining and data mining: combined real-time and retrospective approaches for the identification of emerging novel psychoactive substances. J Forensic Sci. 2020;65(2):550–562.
  • Hertz S. Summary review for regulatory action: food and drug administration. 2016. [accessed April 20, 2021]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2017/208411s001SumR.pdf
  • Peprah K, Frey N. Intranasal and intramuscular naloxone for opioid overdose in the pre-hospital setting: a review of comparative clinical and cost-effectiveness, and guidelines [Internet]. Ottawa (Canada): Canadian Agency for Drugs and Technologies in Health; 2017. p. 6.
  • Dwyer JB, Janssen J, Luckasevic TM, et al. Report of increasing overdose deaths that include acetyl fentanyl in multiple counties of the Southwestern region of the commonwealth of Pennsylvania in 2015–2016. J Forensic Sci. 2018;63(1):195–200.
  • Fort C, Curtis B, Nichols C, et al. Acetyl fentanyl toxicity: two case reports. J Anal Toxicol. 2016;40(9):754–757.
  • Lozier MJ, Boyd M, Stanley C, et al. Acetyl fentanyl, a novel fentanyl analog, causes 14 overdose deaths in Rhode Island, March–May 2013. J Med Toxicol. 2015;11(2):208–217.
  • Delcher C, Wang Y, Vega RS, et al. Carfentanil outbreak – Florida, 2016–2017. Morb Mortal Wkly Rep. 2020;69(5):125–129.
  • Suzuki J, El-Haddad S. A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107–116.
  • Capper SJ, Loo S, Geue JP, et al. Pharmacokinetics of fentanyl after subcutaneous administration in volunteers. Eur J Anaesthesiol. 2010;27(3):241–246.
  • Fung DL, Eisele JH. Fentanyl pharmacokinetics in awake volunteers. J Clin Pharmacol. 1980;20(11):652–658.
  • McClain DA, Hug CC. Jr. Intravenous fentanyl kinetics. Clin Pharmacol Ther. 1980;28(1):106–114.
  • Bleeker CP, Bremer RC, Dongelmans DA, et al. Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain, a case report. Eur J Pain. 2001;5(3):325–329.
  • McIntyre IM, Gary RD, Estrada J, et al. Antemortem and postmortem fentanyl concentrations: a case report. Int J Legal Med. 2014;128(1):65–67.
  • Kuip EJ, Zandvliet ML, Koolen SL, et al. A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients. Br J Clin Pharmacol. 2017;83(2):294–313.
  • Lim SY, Woo S, Miller JL, et al. Prediction and comparison of fentanyl infusion pharmacokinetics in obese and nonobese children. Pediatr Crit Care Med. 2019;20(12):e556–e564.
  • Nedahl M, Johansen S, Linnet K. Postmortem brain-blood ratios of codeine, fentanyl, oxycodone and tramadol. J Anal Toxicol. 2021;45(1):53–59.
  • Carpenter J, Murray BP, Atti S, et al. Naloxone dosing after opioid overdose in the era of illicitly manufactured fentanyl. J Med Toxicol. 2020;16(1):41–48.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.